The announced partnership is with Seraly Dermatology in Pittsburgh, Pennsylvania. The customer will integrate several Nevisense systems into their skin cancer detection workflow. According to Seraly Dermatology’s website, they have a single location with a staff of 5, so the client seems to be small. Still, each customer win is a sign that the market response to Nevisense remains good and that the product continues to be well positioned.

SciBase mentioned in the press release that they are expanding to a new market. We assume Seraly Dermatology was their first customer in Pennsylvania, which could indicate that insurance coverage for Nevisense diagnostics in the state is on a positive trend. Our revenue growth estimates for Scibase assume steady customer wins, so this deal will not cause any changes to our revenue forecasts.